March 20, 2025 3:45 PM
Eli Lilly launches Mounjaro in India for obesity and diabetes treatment
Global pharmaceutical company Eli Lilly has launched Mounjaro (tirzepatide) in India, a groundbreaking drug designed for the treatment of Type 2 diabetes and obesity. Approved by the Central Drugs Standard Control Organization (CDSCO), Mounjaro is now available in single-dose vials, with pricing set at Rs 3,500 for a 2.5 mg vial and Rs 4,375 for a 5 mg vial. The estimated monthly cost of treatment ranges between Rs 14,000 and Rs 17,500, depending on the dosage prescribed. Eli Lilly claims that...